tiprankstipranks
Advertisement
Advertisement
GH Research to Present New GH001 Phase 2b Data in Treatment-Resistant Depression at ASCP 2026
PremiumCompany AnnouncementsGH Research to Present New GH001 Phase 2b Data in Treatment-Resistant Depression at ASCP 2026
1M ago
GH Research price target lowered to $65 from $70 at H.C. Wainwright
Premium
The Fly
GH Research price target lowered to $65 from $70 at H.C. Wainwright
1M ago
GH Research price target raised to $35 from $25 at Cantor Fitzgerald
Premium
The Fly
GH Research price target raised to $35 from $25 at Cantor Fitzgerald
2M ago
GH Research reports Q1 EPS (31c), consensus (26c)
PremiumThe FlyGH Research reports Q1 EPS (31c), consensus (26c)
2M ago
GH Research Posts Wider Q1 2026 Loss as R&D and Admin Costs Rise
Premium
Company Announcements
GH Research Posts Wider Q1 2026 Loss as R&D and Admin Costs Rise
2M ago
GH Research Sets June 25, 2026 AGM and Tables Board, Auditor Votes
Premium
Company Announcements
GH Research Sets June 25, 2026 AGM and Tables Board, Auditor Votes
2M ago
Trump Trade: President to sign order on psychedelic used for PTSD
PremiumThe FlyTrump Trade: President to sign order on psychedelic used for PTSD
3M ago
Trump to sign order on psychedelic used for PTSD, CBS News says
Premium
The Fly
Trump to sign order on psychedelic used for PTSD, CBS News says
3M ago
Psychedelic: Compass Pathways, NRx Pharma report earnings results
Premium
The Fly
Psychedelic: Compass Pathways, NRx Pharma report earnings results
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100